Dexamethasone-sparing antiemetic strategies (day-1-only, reduced-dose and dexamethasone-free regimens) versus guideline-standard dexamethasone for the prevention of chemotherapy-induced nausea and vomiting: a systematic review and non-inferiority meta-analysis of randomised controlled trials with trial sequential analysis (DEX-SPARE)
- DOI
- 10.17605/osf.io/s9r7a
- Published
- 2026
- Container
- Not recorded
- Publisher
- OSF Registries
- Open access
- yes
Credibility signals
limited evidence Score 47/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- supportingPublication license: A publication license was supplied: https://creativecommons.org/licenses/by/4.0/legalcode. Presence improves reuse transparency, not research validity.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.17605/osf.io/s9r7a,
title = {Dexamethasone-sparing antiemetic strategies (day-1-only, reduced-dose and dexamethasone-free regimens) versus guideline-standard dexamethasone for the prevention of chemotherapy-induced nausea and vomiting: a systematic review and non-inferiority meta-analysis of randomised controlled trials with trial sequential analysis (DEX-SPARE)},
author = {Xiaofen Pan and mengyuan zhu and Shan Huang},
year = {2026},
doi = {10.17605/osf.io/s9r7a},
url = {https://doi.org/10.17605/osf.io/s9r7a}
}RIS
TY - JOUR TI - Dexamethasone-sparing antiemetic strategies (day-1-only, reduced-dose and dexamethasone-free regimens) versus guideline-standard dexamethasone for the prevention of chemotherapy-induced nausea and vomiting: a systematic review and non-inferiority meta-analysis of randomised controlled trials with trial sequential analysis (DEX-SPARE) AU - Xiaofen Pan AU - mengyuan zhu AU - Shan Huang PY - 2026 DO - 10.17605/osf.io/s9r7a UR - https://doi.org/10.17605/osf.io/s9r7a ER -
APA
Pan, X., zhu, M., & Huang, S. (2026). Dexamethasone-sparing antiemetic strategies (day-1-only, reduced-dose and dexamethasone-free regimens) versus guideline-standard dexamethasone for the prevention of chemotherapy-induced nausea and vomiting: a systematic review and non-inferiority meta-analysis of randomised controlled trials with trial sequential analysis (DEX-SPARE). https://doi.org/10.17605/osf.io/s9r7a
Source records
- datacite · retrieved 2026-11-09T18:20:11.606Z